World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
63
Citations
16307
World Ranking
1793
National Ranking
895

Srinivasan Yegnasubramanian publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Srinivasan Yegnasubramanian sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 230 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Srinivasan Yegnasubramanian D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Srinivasan Yegnasubramanian sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 63 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Srinivasan Yegnasubramanian is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans across Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology, and Cancer Research.

Their recent academic output includes significant contributions published in prominent venues such as Nature, Nature Reviews Urology, Cell Reports, and the Journal of Clinical Investigation. Notable papers include:

  • Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers (2021, Nature)
  • Genomic and phenotypic heterogeneity in prostate cancer (2020, Nature Reviews Urology)
  • Metabolic programs define dysfunctional immune responses in severe COVID-19 patients (2021, Cell Reports)
  • A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target (2020, Journal of Clinical Investigation)
  • Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses (2021, Journal of Clinical Investigation)

Yegnasubramanian's research interests focus predominantly on prostate cancer treatment and research, cancer immunotherapy and biomarkers, cancer genomics and diagnostics, epigenetics and DNA methylation, immune cells in cancer, immunotherapy and immune responses, and CAR-T cell therapy research.

Frequent co-authors who have collaborated extensively with Yegnasubramanian include:

  • Angelo M. De Marzo
  • William G. Nelson
  • Jessica Hicks
  • Rulin Wang
  • Ajay Vaghasia

The scientist has regularly published in several key journals and preprint servers. Their most frequent publication venues are:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Prostate
  • JCI Insight
  • Nature Communications

Their work intersects multiple disciplines, with 176 publications classified under Medicine and 115 publications in Biochemistry, Genetics and Molecular Biology. Subfields prominently represented include 72 in Molecular Biology, 51 in Oncology, 49 in Pulmonary and Respiratory Medicine, 44 in Immunology, and 35 in Cancer Research.

This comprehensive research portfolio illustrates a focus on molecular mechanisms and clinical applications related to cancer and immune responses, contributing to the broader understanding of oncology and immunology through interdisciplinary approaches.

Best Publications

  • Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

    Wennuan Liu;Sari Laitinen;Sofia Khan;Mauno Vihinen

  • Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

    Michael C Haffner;Martin J Aryee;Antoun Toubaji;David M Esopi

  • Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

    Rong Hu;Changxue Lu;Elahe A. Mostaghel;Srinivasan Yegnasubramanian

  • Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

    Srinivasan Yegnasubramanian;Jeanne Kowalski;Mark L. Gonzalgo;Marianna Zahurak

  • Tracking the clonal origin of lethal prostate cancer.

    Michael C. Haffner;Timothy Mosbruger;David M. Esopi;Helen Fedor

  • miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.

    Judit Ribas;Xiaohua Ni;Michael Haffner;Erik A. Wentzel

  • Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

    Michael C Haffner;Alcides Chaux;Alan K. Meeker;David M Esopi

  • The inflammatory microenvironment and microbiome in prostate cancer development

    Karen S. Sfanos;Srinivasan Yegnasubramanian;William G. Nelson;Angelo M. De Marzo

  • Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth

    Ping Zhang;Anju Singh;Srinivasan Yegnasubramanian;David Esopi

  • Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.

    Philipp Nuhn;Johann S. De Bono;Karim Fizazi;Stephen J. Freedland;Stephen J. Freedland

  • Procainamide is a specific inhibitor of DNA methyltransferase 1.

    Byron H. Lee;Srinivasan Yegnasubramanian;Xiaohui Lin;William G. Nelson

  • MYC and Prostate Cancer

    Cheryl M. Koh;Charles J. Bieberich;Chi V. Dang;William G. Nelson

  • Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.

    Justina X. Caushi;Jiajia Zhang;Zhicheng Ji;Zhicheng Ji;Ajay Vaghasia

  • Genomic and phenotypic heterogeneity in prostate cancer.

    Michael C. Haffner;Michael C. Haffner;Michael C. Haffner;Wilbert Zwart;Martine P. Roudier;Lawrence D. True

  • DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity

    Srinivasan Yegnasubramanian;Michael C. Haffner;Yonggang Zhang;Bora Gurel

  • GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.

    Masashi Nakayama;Mark L. Gonzalgo;Srinivasan Yegnasubramanian;Xiaohui Lin

  • A DNA hypermethylation module for the stem/progenitor cell signature of cancer

    Hariharan Easwaran;Sarah E. Johnstone;Leander Van Neste;Joyce Ohm

  • DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases

    Martin J. Aryee;Wennuan Liu;Julia C. Engelmann;Philipp Nuhn

  • Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

    Michael T. Schweizer;Emmanuel S. Antonarakis;Hao Wang;A. Seun Ajiboye

  • Abstract LB-174: A DNA hypermethylation module for the stem/progenitor cell signature of cancer

    Hariharan Easwaran;Sarah E. Johnstone;Leander Van Neste;Joyce E. Ohm

Frequent Co-Authors

William G. Nelson
William G. Nelson Johns Hopkins University School of Medicine
Angelo M. De Marzo
Angelo M. De Marzo Johns Hopkins University School of Medicine
William B. Isaacs
William B. Isaacs Johns Hopkins University
Sarah J. Wheelan
Sarah J. Wheelan Johns Hopkins University School of Medicine
George J. Netto
George J. Netto University of Alabama at Birmingham
Alan K. Meeker
Alan K. Meeker Johns Hopkins University School of Medicine
Martin J. Aryee
Martin J. Aryee Harvard University
Bruce J. Trock
Bruce J. Trock Johns Hopkins University
Mario A. Eisenberger
Mario A. Eisenberger Johns Hopkins University
Bert Vogelstein
Bert Vogelstein Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to a variety of healthcare and research roles. Many students interested in this field also consider online degree pathways that lead to rewarding health science careers, such as nursing or advanced practitioner roles.

If you're considering fast-tracking your education, options like rn to bsn 6 months programs allow registered nurses to earn their Bachelor of Science in Nursing in as little as half a year. For those aiming for an advanced degree, rn to np bridge programs let aspiring nurses move seamlessly from an associate to a master’s level qualification.

Understanding the professional journey is important. Learn how many years does it take to be a nurse practitioner and compare pathways to choose what fits best for your goals. Career prospects are also a key consideration. Discover the earning potential for advanced practice nurses in the U.S. by checking the latest pmhnp salary guide by state.

These online degrees and clearly defined career pathways provide flexible options for those interested in combining a background in Molecular Biology with clinical practice and healthcare leadership.

Best Scientists Citing Srinivasan Yegnasubramanian

Trending Scientists

Recently Published Articles